Literature DB >> 28943276

Detection of anabolic androgenic steroid use by elite athletes and by members of the general public.

Bradley D Anawalt1.   

Abstract

Because national and international sports competitions are sources of community pride and financial revenue, there have been great efforts to prevent and detect the use of performance-enhancing drugs such as anabolic androgenic steroids by elite athletes. The World Anti-Doping Agency and its national affiliate anti-doping agencies have created sophisticated monitoring systems and advanced testing techniques to detect the use of banned substances including anabolic androgenic steroids by participants in international and national athletic competitions. The creation of a longitudinal monitoring program known as the biological passport is a recent, important development in the efforts to prevent and detect the use of banned performance-enhancing drugs and methods. The biological passport program consists of the measurement of urinary and blood markers of anabolic androgenic steroid use (and other banned drugs or methods) at baseline and at random times. A panel of experts reviews the longitudinal data and interprets the likelihood of the use of banned drugs and methods. These advances in anti-doping appear to be highly effective, but some athletes persist in their efforts to cheat the detection process. In addition, some members of the general public use anabolic androgenic steroids for a variety of reasons including to improve physical appearance or to enhance performance in athletics. Clinicians must depend on clinical acumen and the measurement of serum testosterone and gonadotropins to guide them in making a tentative diagnosis of anabolic androgenic steroid use. Definitive diagnosis requires that the patient disclose the use of the drugs. Because anabolic androgenic steroids are effective for improving certain aspects of physical performance, some elite athletes (and members of the general public) will continue to use these drugs. Effective efforts to curtail the use of these drugs will require decreasing the ease of access to them, continued advancements in laboratory techniques, and perhaps a shift in societal approbation for athletic performance and muscular appearance.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anabolic androgenic steroids; Anti-doping; Biological passport; Sex steroids; Testosterone

Mesh:

Substances:

Year:  2017        PMID: 28943276     DOI: 10.1016/j.mce.2017.09.027

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  5 in total

1.  Severe and protracted cholestasis in 44 young men taking bodybuilding supplements: assessment of genetic, clinical and chemical risk factors.

Authors:  Andrew Stolz; Victor Navarro; Paul H Hayashi; Robert J Fontana; Huiman X Barnhart; Jiezhun Gu; Naga P Chalasani; Maricruz M Vega; Herbert L Bonkovsky; Leonard B Seeff; Jose Serrano; Bharathi Avula; Ikhlas A Khan; Elizabeth T Cirulli; David E Kleiner; Jay H Hoofnagle
Journal:  Aliment Pharmacol Ther       Date:  2019-04-01       Impact factor: 8.171

Review 2.  Diagnosis and Management of Anabolic Androgenic Steroid Use.

Authors:  Bradley D Anawalt
Journal:  J Clin Endocrinol Metab       Date:  2019-07-01       Impact factor: 5.958

Review 3.  Advances in the Determination of Anabolic-Androgenic Steroids: From Standard Practices to Tailor-Designed Multidisciplinary Approaches.

Authors:  Lukáš Huml; Jan Tauchen; Silvie Rimpelová; Barbora Holubová; Oldřich Lapčík; Michal Jurášek
Journal:  Sensors (Basel)       Date:  2021-12-21       Impact factor: 3.576

4.  Detection of anabolic steroids via cyclodextrin-promoted fluorescence modulation.

Authors:  Anna Z Haynes; Mindy Levine
Journal:  RSC Adv       Date:  2020-07-01       Impact factor: 4.036

5.  No association between psychiatric symptoms and doses of anabolic steroids in a cohort of male and female bodybuilders.

Authors:  Julio X Amaral; Andrea C Deslandes; Monica C Padilha; Leonardo Vieira Neto; Luiz E Osorio; Francisco Radler Aquino Neto; Marcelo S Cruz
Journal:  Drug Test Anal       Date:  2022-02-21       Impact factor: 3.234

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.